BioWorld MedTech

Oct. 4, 2018

View Archived Issues

V-Wave kicks off enrollment in pivotal study of device for HF

Israeli startup V-Wave Ltd. reported the start of enrollment in a study of a minimally invasive device to treat patients with New York Heart Association (NYHA) class III and ambulatory class IV symptomatic heart failure (HF). Read More

Lungvision launch seen as step towards winning battle against lung cancer

Read More

Neovasc heads for U.S. with Reducer, a minimally invasive angina implant

Read More

Datascope warning letter cites supplier, design verification issues

Read More

Do drug, device companies meet California's boardroom quota of women?

Read More

Appointments and advancements

Read More

Daily M&A

Read More

Financings

Read More

Regulatory front

Read More

Product briefs

Read More

Other news to note

Read More

BioWorld MedTech's Orthopedics Extra

Read More